28957-08-6Relevant articles and documents
Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells
Luo, Dongdong,Yi, Yujiao,Peng, Kai,Liu, Tangrong,Yang, Jiayu,Liu, Shan,Zhao, Wanzhou,Qu, Xianjun,Yu, Wengong,Gu, Yuchao,Wan, Shengbiao
, p. 365 - 379 (2019)
The biological function of the natural ent-kaurene diterpenoid isolated from genus Isodon, oridonin, has been intensively studied. However, its mechanism studies and clinical applications were hampered by its moderate biological activities. In order to en
Structural modification of oridonin: Via DAST induced rearrangement
Luo, Dong-Dong,Peng, Kai,Yang, Jia-Yu,Piyachaturawat, Pawinee,Saengsawang, Witchuda,Ao, Lei,Zhao, Wan-Zhou,Tang, Yu,Wan, Sheng-Biao
, p. 29548 - 29554 (2018)
A simple and efficient protocol was developed for the syntheses of oridonin analogues, i.e. 6,20-epoxy ent-kaurane diterpenoid analogues from oridonin via diethylaminosulfur trifluoride (DAST) promoted rearrangement, most of which exhibited superior anticancer activities compared with their precursor.
Spirolactone type diterpene spliced hydrogen sulfide donor derivatives as well as preparation method and application thereof
-
Paragraph 0013; 0028; 0030, (2020/09/16)
The invention relates to the field of natural medicines and medicinal chemistry, and relates to spirolactone diterpene spliced hydrogen sulfide donor derivatives as well as a preparation method and application thereof. The invention particularly relates to the preparation method of a series of spirolactone type kaurane diterpene hydrogen sulfide donor derivatives with anti-tumor activity and the application of the derivatives in preparation of anti-tumor drugs. The spirolactone type diterpene hydrogen sulfide donor derivatives and the pharmaceutically acceptable salts thereof are represented by a general formula I or II, wherein R is as described in the claims and the specification.